CCG
CL icon

Chatham Capital Group’s Colgate-Palmolive CL Stock Holding History

Chatham Capital Group’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,160
Closed -$202K – 198
2025
Q1 		$202K Buy
+2,160
New +$193K 0.03% 191
2024
Q4 		– Sell
-2,160
Closed -$224K – 198
2024
Q3 		$224K Hold
2,160
– – 0.04% 188
2024
Q2 		$210K Buy
+2,160
New +$199K 0.04% 186
2018
Q1 		– Sell
-35,110
Closed -$2.65M – 153
2017
Q4 		$2.65M Buy
35,110
+100
+0.3% +$7.3K 0.73% 34
2017
Q3 		$2.55M Buy
35,010
+531
+2% +$38.3K 0.72% 36
2017
Q2 		$2.56M Buy
34,479
+400
+1% +$29.7K 0.71% 37
2017
Q1 		$2.49M Buy
34,079
+1,080
+3% +$75.6K 0.7% 36
2016
Q4 		$2.16M Buy
32,999
+400
+1% +$27.4K 0.63% 42
2016
Q3 		$2.42M Sell
32,599
-800
-2% -$59.1K 0.76% 37
2016
Q2 		$2.44M Buy
33,399
+500
+2% +$35.6K 0.76% 35
2016
Q1 		$2.32M Buy
32,899
+738
+2% +$49.1K 0.73% 35
2015
Q4 		$2.14M Sell
32,161
-1,190
-4% -$79.2K 0.69% 37
2015
Q3 		$2.12M Sell
33,351
-1,331
-4% -$87K 0.71% 35
2015
Q2 		$2.27M Buy
34,682
+3,275
+10% +$222K 0.64% 41
2015
Q1 		$2.18M Buy
31,407
+150
+0.5% +$10.4K 0.64% 39
2014
Q4 		$2.16M Sell
31,257
-300
-1% -$20.3K 0.65% 41
2014
Q3 		$2.06M Buy
31,557
+1,357
+4% +$89.5K 0.64% 41
2014
Q2 		$2.06M Buy
30,200
+700
+2% +$46.9K 0.81% 37
2014
Q1 		$1.91M Buy
29,500
+200
+0.7% +$12.6K 0.79% 38
2013
Q4 		$1.91M Buy
29,300
+250
+0.9% +$16K 0.79% 37
2013
Q3 		$1.72M Buy
29,050
+1,300
+5% +$77K 0.78% 36
2013
Q2 		$1.59M Buy
+27,750
New +$1.65M 0.78% 35

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Chatham Capital Group's CL Position: Q2 2025 in Review

Chatham Capital Group sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 2,160 shares — an estimated $202K sold.

Chatham Capital Group first reported a position in CL in Q2 2013 and held it in 22 quarters. The position peaked at $2.65M in Q4 2017. 1,916 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • Chatham Capital Group reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
  • Chatham Capital Group sold 2,160 Colgate-Palmolive shares in Q2 2025, an estimated $202K.
  • Chatham Capital Group first reported a position in Colgate-Palmolive in Q2 2013 and held it in 22 quarters.
  • Chatham Capital Group's Colgate-Palmolive position peaked at $2.65M in Q4 2017.
  • 1,916 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Chatham Capital Group's 13F filing for Q2 2025, filed 17 Jul 2025.